# Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib
Canonical URL: https://biopharmsignal.com/news/CERT/certara-simcypr-simulator-results-replace-ten-human-trials-for-chronic-myeloid-leukemia-cml-therapy-asciminib
Ticker: CERT
Company: Certara
Source: Certara
Published: 2026-03-03 13:00 EST
Original Source URL: https://ir.certara.com
## Summary

Biosimulation results highlight how model-informed approaches for drug development and regulatory decision-making save time and money.  RADNOR, Pa., March 03, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced its Simcyp ®

## Article Body
Biosimulation results highlight how model-informed approaches for drug development and regulatory decision-making save time and money.  RADNOR, Pa., March 03, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced its Simcyp ®
## Recent Company News
- 2026-05-11 10:25 EST — [Certara Reports First Quarter 2026 Financial Results](https://biopharmsignal.com/news/CERT/certara-reports-first-quarter-2026-financial-results) — Source: Certara
- 2026-04-22 11:00 EST — [Certara Enters Definitive Agreement for the Sale of its Regulatory and Medical Writing Business to Veristat](https://biopharmsignal.com/news/CERT/certara-enters-definitive-agreement-for-the-sale-of-its-regulatory-and-medical-writing-business-to-veristat) — Source: Certara
- 2026-04-09 20:15 EST — [Certara to Report First Quarter 2026 Financial Results on May 11th, 2026](https://biopharmsignal.com/news/CERT/certara-to-report-first-quarter-2026-financial-results-on-may-11th-2026) — Source: Certara
- 2026-03-03 13:00 EST — [Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib](https://biopharmsignal.com/news/CERT/certara-simcypr-simulator-results-replace-ten-human-trials-for-chronic-myeloid-leukemia-cml-therapy-asciminib) — Source: Certara
- 2026-02-27 13:30 EST — [Certara to Participate in Upcoming Investor Conferences](https://biopharmsignal.com/news/CERT/certara-to-participate-in-upcoming-investor-conferences) — Source: Certara
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)